 |
PDBsum entry 7nrf
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Membrane protein
|
PDB id
|
|
|
|
7nrf
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Membrane protein
|
 |
|
Title:
|
 |
Crystal structure of e.Coli bama beta-barrel in complex with darobactin (crystal form 2)
|
|
Structure:
|
 |
Outer membrane protein assembly factor bama. Chain: a. Engineered: yes. Darobactin. Chain: b. Engineered: yes
|
|
Source:
|
 |
Escherichia coli o157:h7. Organism_taxid: 83334. Gene: bama, yaet, z0188, ecs0179. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Synthetic: yes. Synthetic construct. Organism_taxid: 32630
|
|
Resolution:
|
 |
|
2.20Å
|
R-factor:
|
0.219
|
R-free:
|
0.232
|
|
|
Authors:
|
 |
R.P.Jakob,H.Kaur,J.K.Marzinek,R.Green,Y.Imai,J.Bolla,C.Robinson, P.J.Bond,K.Lewis,T.Maier,S.Hiller
|
|
Key ref:
|
 |
H.Kaur
et al.
(2021).
The antibiotic darobactin mimics a β-strand to inhibit outer membrane insertase.
Nature,
593,
125-129.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
03-Mar-21
|
Release date:
|
21-Apr-21
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P0A940
(BAMA_ECOLI) -
Outer membrane protein assembly factor BamA from Escherichia coli (strain K12)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
810 a.a.
368 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Nature
593:125-129
(2021)
|
|
PubMed id:
|
|
|
|
|
| |
|
The antibiotic darobactin mimics a β-strand to inhibit outer membrane insertase.
|
|
H.Kaur,
R.P.Jakob,
J.K.Marzinek,
R.Green,
Y.Imai,
J.R.Bolla,
E.Agustoni,
C.V.Robinson,
P.J.Bond,
K.Lewis,
T.Maier,
S.Hiller.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Antibiotics that target Gram-negative bacteria in new ways are needed to resolve
the antimicrobial resistance crisis1-3. Gram-negative bacteria are
protected by an additional outer membrane, rendering proteins on the cell
surface attractive drug targets4,5. The natural compound darobactin
targets the bacterial insertase BamA6-the central unit of the
essential BAM complex, which facilitates the folding and insertion of outer
membrane proteins7-13. BamA lacks a typical catalytic centre, and it
is not obvious how a small molecule such as darobactin might inhibit its
function. Here we resolve the mode of action of darobactin at the atomic level
using a combination of cryo-electron microscopy, X-ray crystallography, native
mass spectrometry, in vivo experiments and molecular dynamics simulations. Two
cyclizations pre-organize the darobactin peptide in a rigid β-strand
conformation. This creates a mimic of the recognition signal of native
substrates with a superior ability to bind to the lateral gate of BamA. Upon
binding, darobactin replaces a lipid molecule from the lateral gate to use the
membrane environment as an extended binding pocket. Because the interaction
between darobactin and BamA is largely mediated by backbone contacts, it is
particularly robust against potential resistance mutations. Our results identify
the lateral gate as a functional hotspot in BamA and will allow the rational
design of antibiotics that target this bacterial Achilles heel.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |